As shown earlier, the mammalian target of rapamycin, a potent inhibitor of autophagy, is a down-stream target of Akt, and chemical inhibition of the PI3K/Akt pathway in PTEN-deficit glioma cell lines increases autophagy [47]. Here, AKT1 is linked to central nervous system cancer.